High Cholesterol: diet, medications, statin risks and benefits, ApoB and Lp(a), supplements more

This video reviews the basics of high cholesterol, what we look at in a lipid panel including: a discussion about ApoB and Lp(a), what LDL levels we target based on cardiac guidelines, how we manage and treat high cholesterol levels including dietary recommendations, secondary causes of high cholesterol, general dietary guidelines including the general recommendation against excessive saturated fat, common myths and half-truths regarding statin therap, alternative medical therapies we use to lower cholesterol and triglyceride levels, and why I don't recommend using over the counter (OTC) supplements like red rice yeast or OTC omega-3-fatty-acids.

*This video is purely for educational purposes and is not meant to replace medical care. If you have general knowledge questions about cholesterol I'm happy to answer them but I cannot answer specific questions about your personal medical care. As always, if you are concerned with your treatment or lab values then talk to your doctor.

Citations:
1. Mach, F. et al. (2019) ‘2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk’, European Heart Journal, 41(1), pp. 111–188. doi:10.1093/eurheartj/ehz455.
2. Kolominsky, J. (2020a) Familial hypercholesterolemia: Cardiovascular risk stratification and clinical management, American College of Cardiology. Available at: https://www.acc.org/latest-in-cardiol...
3. Virani, S, Morris, P, Agarwala, A. et al. 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee. JACC. 2021 Aug, 78 (9) 960–993. https://doi.org/10.1016/j.jacc.2021.0...
4. Belardo D, et al. Practical, Evidence-Based Approaches to Nutritional Modifications to Reduce Atherosclerotic Cardiovascular Disease: An American Society For Preventive Cardiology Clinical Practice Statement. Am J Prev Cardiol. 2022 Mar 2;10:100323. doi: 10.1016/j.ajpc.2022.100323. PMID: 35284849; PMCID: PMC8914096.
5. Bellissimo, M, Hundley, W. Low-Carbohydrate High-Fat Diets, Lipid Levels, and Cardiovascular Risk∗ . JACC Adv. 2024 Jun, 3 (6). https://doi.org/10.1016/j.jacadv.2024...
6. Zhong VW, Van Horn L, Greenland P, et al. Associations of Processed Meat, Unprocessed Red Meat, Poultry, or Fish Intake With Incident Cardiovascular Disease and All-Cause Mortality. JAMA Intern Med. 2020;180(4):503–512. doi:10.1001/jamainternmed.2019.6969
7. Collins R, Reith C, Emberson J, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 2016;388: 2532-61.
8. Mach F, Ray KK, Wiklund O, et al., for the European Atherosclerosis Society Consensus Panel. Adverse effects of statin therapy: percep- tion vs. the evidence—focus on glucose homeo- stasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Eur Heart J 2018;39:2526–39.
9. Newman CB, Preiss D, Tobert JA, et al. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol 2019;39:e38–81.
10. Berger JS. Aspirin for Primary Prevention—Time to Rethink Our Approach. JAMA Netw Open. 2022;5(4):e2210144. doi:10.1001/jamanetworkopen.2022.10144
11. Zhou, Z, Ryan, J, Ernst, M. et al. Effect of Statin Therapy on Cognitive Decline and Incident Dementia in Older Adults. JACC. 2021 Jun, 77 (25) 3145–3156. https://doi.org/10.1016/j.jacc.2021.0...
12. Cannon, C.P. et al. (2015) ‘Ezetimibe added to statin therapy after acute coronary syndromes’, New England Journal of Medicine, 372(25), pp. 2387–2397. doi:10.1056/nejmoa1410489.
13. Sabatine, M.S. et al. (2017) ‘EVOLOCUMAB and clinical outcomes in patients with cardiovascular disease’, New England Journal of Medicine, 376(18), pp. 1713–1722. doi:10.1056/nejmoa1615664.
14. Raal, F.J. et al. (2020) ‘Inclisiran for the treatment of heterozygous familial hypercholesterolemia’, New England Journal of Medicine, 382(16), pp. 1520–1530. doi:10.1056/nejmoa1913805.
15. Cohen, P. A., Avula, B., & Khan, I. A. (2017). Variability in strength of red yeast rice supplements purchased from mainstream retailers. European Journal of Preventive Cardiology, 24(13), 1431–1434. https://doi.org/10.1177/2047487317715714
16. Hasific, S, Oevrehus, K, Lindholt, J. et al. Effects of Vitamin K2 and D Supplementation on Coronary Artery Disease in Men: A RCT. JACC Adv. 2023 Nov, 2 (9). https://doi.org/10.1016/j.jacadv.2023...

#Cardiology #Cardiologist #LifeOfACardiologist #Residency #InternalMedicine #Fellowship